Clinical Investigator Awards 2026-2028
0
Days Left
to Enter

SSO is pleased to announce the availability of two Clinical Investigator Awards: an any topic CIA and a second CIA opportunity available due to the generous support of the Appendix Cancer Pseudomyxoma Peritonei Research Foundation (ACPMP).

Clinical Investigator Award 2026-2028

  • Any Topic
  • Supported by SSO

Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award 2026-2028

  • Appendix Cancer Pseudomyxoma Peritonei (PMP): Proposals related to appendiceal mucinous neoplasms, appendiceal adenocarcinomas (including signet ring cell adenocarcinoma and goblet cell adenocarcinoma), and/or PMP of appendiceal origin; with a special interest in proposals that embrace moving this rare malignant tumor type forward to a curative science. 
  • Support by a grant from ACPMP

Clinical Investigator Awards promote patient-focused research conducted by surgical oncologists in clinical and translational science. Awards are funded for two years at $50,000/year for a total award of $100,000 beginning April 1 of the award year and concluding March 31 of the 2nd year. (Example: April 1, 2026-MArch 31, 2028). Applicants may apply more than once but may only receive the award one time.

 

Eligibility

  • Must be a surgical oncologist within eight (8) years of completion of fellowship or related training
  • Must be an SSO U.S. member in good standing for at least six (6) months prior to application
    submission to be eligible for an award.

Applicants should play a central role in the conduct of a specific research project. This may include, for example, a leadership role in a clinical research project, a prospective cancer outcomes study, or a translational research project related to a prospective clinical research project. Projects are intended to be clinical or translational in nature, not bench science.

  • Clinical Research: Research in which people, or data, or samples of tissue from people, are studied to understand health and disease. Clinical research helps find new and better ways to detect, diagnose, treat, and prevent disease. Types of clinical research include clinical trials, which test new treatments for a disease, and natural history studies, which collect health information to understand how a disease develops and progresses over time.
  • Translational Research: A term used to describe the process by which the results of research done in the laboratory are used to develop new ways to diagnose and treat disease (i.e., taking research into real world scenarios).

The project must be hypothesis-driven and patient-oriented using the National Institutes of Health (NIH) definition of patient-oriented research: research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. Translational research projects that involve animals are allowed if they also involve some component of human subjects’ research as defined above.

While the applicant does not have to be the principal investigator or the lead institutional investigator, the extent to which the applicant is involved in the study design and conduct must be clearly articulated. Ideal applicants will be early to mid-career investigators with a track record of peer-reviewed research funding who are seeking additional extramural support to further clinical cancer research. This award is not intended to serve as a career development award for new investigators seeking to initiate their research careers. SSO does not support research for commercial benefit or industry development.

See Call for Proposals for detailed application rules and guidance.

For any questions relating to your submission, please contact Nick Sautter, Assistant Director of Scientific Initiatives at: nicholassautter@surgonc.org